Expand TVGN Menu
TVGN MENU

TVGN Latest Press Releases

-- May 28, 2026 --

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue Globe Newswire 12:30 PM

-- May 21, 2026 --

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization Globe Newswire 12:15 PM

-- May 18, 2026 --

Letter to Shareholders from CEO Dr. Ryan Saadi Globe Newswire 12:15 PM

-- May 12, 2026 --

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close Globe Newswire 11:45 AM

-- April 27, 2026 --

Tevogen.AI Nears Completion of PredicTcell Training; Initiates Commercial Readiness and Debuts Internal Application Portal Globe Newswire 11:50 AM

-- March 26, 2026 --

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth Globe Newswire 12:45 PM

-- March 25, 2026 --

Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement Globe Newswire 2:20 PM

-- March 18, 2026 --

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) Globe Newswire 12:22 PM

-- March 13, 2026 --

Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization Globe Newswire 2:45 PM
Tevogen.AI Reports Advancements in PredicTcell Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure Globe Newswire 12:30 PM

-- March 11, 2026 --

Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform Globe Newswire 3:15 PM

-- March 9, 2026 --

Tevogen Names Leadership Team to Execute Diversified Growth Strategy Globe Newswire 7:45 AM

-- March 6, 2026 --

Letter to Shareholders from CEO Dr. Ryan Saadi Globe Newswire 3:40 PM

-- March 5, 2026 --

Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical Globe Newswire 2:50 PM

-- March 4, 2026 --

Tevogen Announces Reverse Stock Split Globe Newswire 8:00 AM

-- February 27, 2026 --

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization Globe Newswire 2:20 PM

-- February 26, 2026 --

UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus Globe Newswire 4:22 PM
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus Globe Newswire 9:20 AM

-- January 30, 2026 --

Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders Globe Newswire 3:00 PM

-- January 29, 2026 --

Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue Globe Newswire 2:45 PM

-- January 12, 2026 --

Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025 Globe Newswire 9:00 AM
Market Data Delayed 15 Minutes